(Q44125962)

30 November 2017

title

Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone (English)

1 reference

30 November 2017

0 references

1

Joseph K Belanoff

0 references

author name string

Joseph K Belanoff

1

1 reference

30 November 2017

Jennifer Jurik

2

1 reference

30 November 2017

Lindsey D Schatzberg

3

1 reference

30 November 2017

Charles DeBattista

4

1 reference

30 November 2017

Alan F Schatzberg

5

1 reference

30 November 2017

publication date

1 August 2002

1 reference

Journal of Molecular Neuroscience

30 November 2017

published in

1 reference

30 November 2017

volume

19

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

201-206

1 reference

Rapid reversal of psychotic depression using mifepristone

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0033-3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0033-3

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0033-3

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0033-3

Cognitive effects of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0033-3

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

21 January 2018

1 reference

12 December 2020

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

1 reference

12 December 2020

HPA axis responsivity to dexamethasone and cognitive impairment in dementia.

1 reference

12 December 2020

Corticosteroid modulation of hippocampal potentials: increased effect with aging

1 reference

12 December 2020

Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory

1 reference

12 December 2020

The Brain as a Target for Steroid Hormone Action

1 reference

12 December 2020

Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups.

1 reference

12 December 2020

The Endocrine Effects of Long-Term Treatment with Mifepristone (RU 486)

1 reference

12 December 2020

1 reference

12 December 2020

Glucocorticoid-induced impairment in declarative memory performance in adult humans

1 reference

12 December 2020

Cortisol's effects on human mental functioning

1 reference

12 December 2020

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

1 reference

12 December 2020

No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease

1 reference

12 December 2020

Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects

1 reference

12 December 2020

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Memory impairment in Cushing's disease.

1 reference

12 December 2020

10.1007/S12031-002-0033-3

Identifiers

DOI

1 reference

30 November 2017

1 reference